Understanding Thalassemia in Pregnancy

Understanding Thalassemia in Pregnancy

Why Early Fetal Testing Can Save Lives

Thalassemia is one of the most common inherited blood disorders in the world, especially in countries like India, where carrier rates remain high in several communities. While many carriers are completely healthy and unaware of their status, two carrier parents can pass on severe disease to their baby.

Modern fetal medicine now allows us to detect serious forms of thalassemia during pregnancy — often early enough to help parents make informed decisions and plan treatment.

What is Thalassemia?

Thalassemia is a genetic disorder affecting hemoglobin, the protein inside red blood cells that carries oxygen.

There are two major forms:

  • Alpha Thalassemia
  • Beta Thalassemia

The disease severity can range from:

  • Silent carrier state
  • Mild anemia
  • Severe lifelong transfusion-dependent disease

The most severe forms may cause:

  • Recurrent blood transfusions
  • Growth problems
  • Iron overload
  • Heart and liver complications
  • Fetal hydrops and fetal death in some alpha-thalassemia syndromes

Why is Antenatal Testing Important?

Early diagnosis during pregnancy helps:

✔️ Identify carrier couples

✔️ Detect affected fetuses early

✔️ Prevent severe disease burden

✔️ Enable informed reproductive choices

✔️ Plan fetal monitoring and treatment

✔️ Reduce emotional and financial stress for families

If both parents are carriers, every pregnancy carries:

  • 25% chance of affected baby
  • 50% chance of carrier baby
  • 25% chance of unaffected baby

Who Should Be Tested?

Testing is strongly recommended when:

  • There is family history of thalassemia
  • Parents belong to high-risk ethnic groups
  • Routine blood tests show:
    • Low MCV
    • Low MCH
    • Unexplained anemia
  • Previous child affected with thalassemia
  • Consanguineous marriage
  • Abnormal fetal ultrasound findings

Step 1: Maternal Screening During Pregnancy

Complete Blood Count (CBC)

The first clue is often:

  • Low hemoglobin
  • Low MCV
  • Low MCH

However, iron deficiency must be differentiated from thalassemia trait.

Hemoglobin Electrophoresis / HPLC

This test identifies abnormal hemoglobin patterns.

Important markers:

  • Elevated HbA2 → suggests beta-thalassemia trait
  • HbF abnormalities
  • Variant hemoglobins

This is one of the most important screening tests in pregnancy.

Step 2: Paternal Testing

If the mother is a carrier, the father must also be tested.

If:

  • Only one parent is carrier → baby usually safe
  • Both parents are carriers → fetus at risk

This is the stage where fetal medicine specialists and genetic counsellors become extremely important.

Step 3: Fetal Testing During Pregnancy

Chorionic Villus Sampling (CVS)

Timing:

Usually performed at 11–14 weeks

Procedure:

A small placental sample is collected under ultrasound guidance.

Advantage:

  • Early diagnosis
  • Early decision-making
  • Highly accurate DNA analysis

This is the most commonly used prenatal diagnostic test for thalassemia.

Amniocentesis

Timing:

Usually after 15 weeks

Procedure:

Amniotic fluid is sampled and fetal DNA is analyzed.

Used when:

  • CVS was not done
  • Late referral
  • Additional genetic studies needed
DNA Mutation Analysis

The fetal sample undergoes molecular testing to identify:

  • Beta-globin mutations
  • Alpha-globin deletions
  • Specific familial mutations

This provides definitive diagnosis.

Can Ultrasound Detect Thalassemia?

Ultrasound may suggest severe disease in some cases.

Findings may include:

  • Fetal anemia
  • Enlarged heart
  • Hydrops fetalis
  • Placental thickening
  • Increased MCA Doppler velocity

However, ultrasound alone cannot confirm thalassemia.

Genetic testing remains essential.

Role of Fetal Medicine Specialists

A fetal medicine specialist helps by:

  • Identifying at-risk pregnancies
  • Performing CVS or amniocentesis
  • Conducting detailed fetal scans
  • Monitoring fetal anemia
  • Coordinating genetic counselling
  • Planning delivery and neonatal care

Emerging Advances

Modern advances now include:

  • Preimplantation genetic testing (PGT)
  • Non-invasive prenatal testing research
  • Improved molecular diagnostics
  • Intrauterine transfusion in selected fetal anemia cases
  • Better survival with modern hematology care

Final Thoughts

Thalassemia is preventable through awareness, screening, and timely prenatal diagnosis. In a country like India, where carrier frequency remains significant, antenatal screening is not just a medical recommendation — it is a public health necessity.

Early testing empowers families with knowledge, improves outcomes, and helps reduce the burden of severe transfusion-dependent thalassemia in future generations.

Dr (Major) Prakash Iyer

Consultant in Fetal Medicine

Book An APPOINTMENT

CALL US